| Property | Value |
|----------|-------|
| **Protein Name** | Nicotinic acetylcholine receptor subunit alpha-1 |
| **Gene** | [CHRNA1](/genes/chrna1) |
| **UniProt ID** | [P30531](https://www.uniprot.org/uniprot/P30531) |
| **PDB ID** | 2QC1, 5KLE |
| **Molecular Weight** | ~55 kDa |
| **Subcellular Localization** | Plasma membrane (ligand-gated ion channel) |
| **Protein Family** | Cys-loop receptor family; Nicotinic acetylcholine receptor |
Nicotinic acetylcholine receptor subunit alpha-1 is a protein encoded by the CHRNA1 gene that in the normal nervous system, chrna1 is primarily expressed at the neuromuscular junction where it mediates neuromuscular signaling:. This page describes its structure, normal nervous system function, role in neurodegenerative disease, and potential as a therapeutic target.
The CHRNA1 protein encodes the alpha-1 subunit of the nicotinic acetylcholine receptor (nAChR), a ligand-gated ion channel composed of five subunits (2 alpha, 1 beta, 1 delta, 1 gamma/epsilon). The protein contains:
- Extracellular N-terminal domain: Contains the acetylcholine binding site
- Cys-loop motif: Characteristic of the Cys-loop receptor family
- Four transmembrane domains (M1-M4): Form the ion channel pore
- Intracellular loop: Between M3 and M4, involved in channel trafficking and regulation
The alpha-1 subunit can form receptors with beta-1, delta, and gamma (fetal) or epsilon (adult) subunits at the neuromuscular junction.
In the normal nervous system, CHRNA1 is primarily expressed at the neuromuscular junction where it mediates neuromuscular signaling:
- Neuromuscular transmission: Binds acetylcholine released from motor neurons to trigger muscle contraction
- Fast synaptic signaling: Mediates excitatory neurotransmission at the motor endplate
- Muscle fiber type specification: Influences development and maintenance of neuromuscular junctions
CHRNA1 receptors are also expressed in some neuronal populations in the CNS, where they contribute to cholinergic signaling.
While CHRNA1 is primarily associated with neuromuscular junction function, it has relevance to neurodegenerative processes:
- Cholinergic neurons degenerate in AD, leading to loss of nAChR signaling
- Alpha-1 subunit expression may be affected in spinal motor neurons in AD
- Relationship to neuromuscular dysfunction observed in some AD patients
- CHRNA1 aggregates have been reported in some ALS models
- Motor neuron degeneration involves disrupted neuromuscular signaling
- Potential role in excitotoxicity mechanisms
- Congenital myasthenic syndromes involve CHRNA1 mutations
- May contribute to neuromuscular weakness in neurodegenerative diseases
- Nicotinic agonists: Compounds targeting alpha-1 containing receptors for neuromuscular disorders
- Positive allosteric modulators: Enhance receptor function in hypofunctional states
- Gene therapy approaches for congenital myasthenic syndromes
- Stem cell-derived motor neurons for disease modeling